Related Experiment Video
Updated: May 5, 2026

04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
6.9K
Gemcitabine-induced thrombotic microangiopathy.
1Cancer and Palliative Care Services, Toowoomba Health Service, Toowoomba, Queensland, Australia.
Internal Medicine Journal
|November 19, 2013
Summary
Thrombotic microangiopathy (TMA) is a serious condition affecting small blood vessels. This report details two cases where gemcitabine chemotherapy led to the development of TMA.
Area of Science:
- Oncology
- Hematology
- Nephrology
Background:
- Thrombotic microangiopathy (TMA) is a critical disorder involving platelet aggregation and end-organ damage.
- While often idiopathic, certain drug classes, including cytotoxic chemotherapy, are implicated in TMA development.
Observation:
- Gemcitabine, a widely used chemotherapy agent, has been increasingly associated with TMA.
- This report presents two distinct patient cases experiencing TMA during gemcitabine treatment.
Findings:
- The documented cases highlight a potential link between gemcitabine administration and the onset of TMA.
- The incidence of gemcitabine-induced TMA may rise with its expanding clinical application.
Implications:
- Awareness of gemcitabine-induced TMA is crucial for oncologists and hematologists.
- Early recognition and management strategies are vital for patients undergoing gemcitabine chemotherapy to mitigate TMA risks.
Related Concept Videos
Drugs that Destabilize Microtubules
3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Cytomegalovirus Disease
108
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
108
